Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129 · see citing works

Pathogenesis of NIDDM. A balanced overview.

DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085 · see citing works

Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?

Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.1 · Cited by 1,482 · see citing works

Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women

Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339 · see citing works

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,328 · see citing works

Fatty acid-induced β cell apoptosis: A link between obesity and diabetes

Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142 · see citing works

Five stages of evolving beta-cell dysfunction during progression to diabetes

Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126 · see citing works

Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes

Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078 · see citing works

Mechanisms of β-Cell Death in Type 2 Diabetes

Donath, M. Y., Ehses, J. A., Maedler, K., Schumann, D. M., Ellingsgaard, H., Eppler, E., & Reinecke, M. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s108 · Cited by 444 · see citing works

β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats

Finegood, D. T., McArthur, M. D., Kojwang, D., Thomas, M. J., Topp, B. G., Leonard, T. B., & Buckingham, R. E. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1021 · Cited by 375 · see citing works

Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?

Taylor, S. I., Accili, D., & Imai, Y. (1994) · Diabetes · doi:10.2337/diab.43.6.735 · Cited by 289 · see citing works

Neuronal Pathway from the Liver Modulates Energy Expenditure and Systemic Insulin Sensitivity

Uno, K., Katagiri, H., Yamada, T., Ishigaki, Y., Ogihara, T., Imai, J., Hasegawa, Y., Gao, J., Kaneko, K., Iwasaki, H., et al. (2006) · Science · doi:10.1126/science.1126010 · Cited by 261 · see citing works

Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: Possible role of oxidative stress

Piro, S., Anello, M., Pietro, C. D., Lizzio, M. N., Patan�, G., Rabuazzo, A. M., Vigneri, R., Purrello, M., & Purrello, F. (2002) · Metabolism · doi:10.1053/meta.2002.35200 · Cited by 250 · see citing works

New Oral Therapies for Type 2 Diabetes Mellitus: The Glitazones or Insulin Sensitizers

Mudaliar, S. R. D., & Henry, R. R. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.239 · Cited by 247 · see citing works

Thiazolidinediones improve β-cell function in type 2 diabetic patients

Gastaldelli, A., Ferrannini, E., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00551.2006 · Cited by 200 · see citing works

Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes

Kaneto, H., Matsuoka, T.-A., Nakatani, Y., Kawamori, D., Miyatsuka, T., Matsuhisa, M., & Yamasaki, Y. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0640-x · Cited by 193 · see citing works

Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells

Dubois, M., Pattou, F. N., Kerr-Conte, J. A., Gmyr, V., Vandewalle, B., Desreumaux, P., Auwerx, J. H., Schoonjans, K., & Lefèbvre, J. (2000) · Diabetologia · doi:10.1007/s001250051508 · Cited by 189 · see citing works

Peroxisome Proliferator-activated Receptor γ-mediated Regulation of Neural Stem Cell Proliferation and Differentiation

Wada, K., Nakajima, A., Katayama, K., Kudo, C., Shibuya, A., Kubota, N., Terauchi, Y., Tachibana, M., Miyoshi, H., Kamisaki, Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513786200 · Cited by 165 · see citing works

TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.

Azen, S., Peters, R., Berkowitz, K., Kjos, S., Xiang, A., & Buchanan, T. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00151-7 · Cited by 164 · see citing works

Chronic Hyperglycemia, Independent of Plasma Lipid Levels, Is Sufficient for the Loss of β-Cell Differentiation and Secretory Function in the db/db Mouse Model of Diabetes

Kjørholt, C., Åkerfeldt, M. C., Biden, T. J., & Laybutt, D. R. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2755 · Cited by 145 · see citing works

Targeted Elimination of Peroxisome Proliferator-Activated Receptor γ in β Cells Leads to Abnormalities in Islet Mass without Compromising Glucose Homeostasis

Rosen, E. D., Kulkarni, R., Sarraf, P., Özcan, U., Okada, T., Hsu, C.-H., Eisenman, D., Magnuson, M. A., Gonzalez, F. J., Kahn, C. R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7222-7229.2003 · Cited by 141 · see citing works

Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice: possible protection of β cells from oxidative stress

Ishida, H., Takizawa, M., Ozawa, S., Nakamichi, Y., Yamaguchi, S., Katsuta, H., Tanaka, T., Maruyama, M., Katahira, H., Yoshimoto, K., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.021 · Cited by 138 · see citing works

Differential Influences of Peroxisome Proliferator–Activated Receptorsγ and -α on Food Intake and Energy Homeostasis

Larsen, P. J., Jensen, P. B., Sørensen, R. V., Larsen, L. K., Vrang, N., Wulff, E. M., & Wassermann, K. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2249 · Cited by 111 · see citing works

Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance

Durbin, R. J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.0348.x · Cited by 108 · see citing works

Preserved Pancreatic β-Cell Development and Function in Mice Lacking the Insulin Receptor-Related Receptor

Kitamura, T., Kido, Y., Nef, S., Merenmies, J. M., Parada, L. F., & Accili, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5624-5630.2001 · Cited by 107 · see citing works

Pioglitazone and Sodium Salicylate Protect Human β-Cells against Apoptosis and Impaired Function Induced by Glucose and Interleukin-1β

Zeender, E., Maedler, K., Bosco, D., Berney, T., Donath, M. Y., & Halban, P. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0446 · Cited by 103 · see citing works

Activation of Peroxisome Proliferator-Activated Receptor-γ by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3′-Kinase-Dependent Pathway

Lin, C., Gurlo, T., Haataja, L., Hsueh, W. A., & Butler, P. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0079 · Cited by 101 · see citing works

Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes

Diani, A. R., Sawada, G., Wyse, B., Murray, F. T., & Khan, M. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00331.2003 · Cited by 100 · see citing works

Structural and functional analysis of pancreatic islets preserved by pioglitazone in <i>db/db</i> mice

Kawasaki, F., Matsuda, M., Kanda, Y., Inoue, H., & Kaku, K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00128.2004 · Cited by 99 · see citing works

Long-Term Treatment With Rosiglitazone and Metformin Reduces the Extent of, but Does Not Prevent, Islet Amyloid Deposition in Mice Expressing the Gene for Human Islet Amyloid Polypeptide

Hull, R. L., Shen, Z.-P., Watts, M. R., Kodama, K., Carr, D. B., Utzschneider, K. M., Zraika, S., Wang, F., & Kahn, S. E. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2235 · Cited by 93 · see citing works

Pioglitazone Reduces Islet Triglyceride Content and Restores Impaired Glucose-Stimulated Insulin Secretion in Heterozygous Peroxisome Proliferator–Activated Receptor-γ–Deficient Mice on a High-Fat Diet

Matsui, J., Terauchi, Y., Kubota, N., Takamoto, I., Eto, K., Yamashita, T., Komeda, K., Yamauchi, T., Kamon, J., Kita, S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2844 · Cited by 92 · see citing works

Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on β-cell function and morphology in db/db mice

Shao, J., Iwashita, N., Ikeda, F., Ogihara, T., Uchida, T., Shimizu, T., Uchino, H., Hirose, T., Kawamori, R., & Watada, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.011 · Cited by 90 · see citing works

Influence of Rosiglitazone Treatment on β-Cell Function in Type 2 Diabetes: Evidence of an Increased Ability of Glucose to Entrain High-Frequency Insulin Pulsatility

Juhl, C. B., Hollingdal, M., Pørksen, N. K., Prange, Å., Lönnqvist, F., & Schmitz, O. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021181 · Cited by 63 · see citing works

Pioglitazone attenuates fatty acid–induced oxidative stress and apoptosis in pancreatic β‐cells

Saitoh, Y., Chun‐ping, C., Noma, K., Ueno, H., Mizuta, M., & Nakazato, M. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00749.x · Cited by 41 · see citing works

Effects of rosiglitazone and metformin on pancreatic beta cell gene expression

Richardson, H., Campbell, S. C., Smith, S. A., & Macfarlane, W. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0155-1 · Cited by 34 · see citing works

Troglitazone acutely activates AMP-activated protein kinase and inhibits insulin secretion from beta cells

Wang, X., Zhou, L., Shao, L., Qian, L., Fu, X., Li, G., Luo, T., Gu, Y., Li, F., Li, J., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.034 · Cited by 31 · see citing works

Expression and functional activity of PPARγ in pancreatic β cells

Welters, H. J., McBain, S. C., Tadayyon, M., Scarpello, J. H. B., Smith, S. A., & Morgan, N. G. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705844 · Cited by 29 · see citing works

PPAR- overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells

Nakamichi, Y., Kikuta, T., Ito, E., Ohara‐Imaizumi, M., Nishiwaki, C., Ishida, H., & Nagamatsu, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01045-3 · Cited by 27 · see citing works

The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats

Choi, S. H., Zhao, Z. S., Lee, Y.-J., Kim, S. K., Kim, D. J., Ahn, C. W., Lim, S. K., Lee, H. C., & Soo, B. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.756 · Cited by 19 · see citing works

Pioglitazone acutely influences glucose-sensitive insulin secretion in normal and diabetic human islets

Zhang, F., Sjöholm, Å., & Zhang, Q. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.103 · Cited by 13 · see citing works

Pancreatic regulation of glucose homeostasis.

Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental &amp; Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985 · see citing works

The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes

Shimoda, M., Kanda, Y., Hamamoto, S., Tawaramoto, K., Hashiramoto, M., Matsuki, M., & Kaku, K. (2011) · Diabetologia · doi:10.1007/s00125-011-2069-9 · Cited by 161 · see citing works

Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future

Davidson, M., Mattison, D. R., Azoulay, L., & Krewski, D. R. (2017) · Critical Reviews in Toxicology · doi:10.1080/10408444.2017.1351420 · Cited by 114 · see citing works

Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents

Bansal, G., Singh, S., Monga, V., Veeraveedu, P. T., & Chawla, P. A. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103271 · Cited by 101 · see citing works

Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?

Carboni, E., Carta, A. R., & Carboni, E. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109776 · Cited by 89 · see citing works

The role of peroxisome proliferator‐activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus

Gupta, D., Kono, T., & Evans‐Molina, C. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01299.x · Cited by 83 · see citing works

The global perspective on peroxisome proliferator-activated receptor γ (PPARγ) in ectopic fat deposition: A review

Qiu, Y., Gan, M., Wang, X., Liao, T., Chen, Q., Lei, Y., Chen, L., Wang, J., Zhao, Y., Niu, L., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127042 · Cited by 83 · see citing works

Beneficial effects of sodium–glucose cotransporter 2 inhibitors for preservation of pancreatic β‐cell function and reduction of insulin resistance

Kaneto, H., Obata, A., Kimura, T., Shimoda, M., Okauchi, S., Shimo, N., Matsuoka, T., & Kaku, K. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12494 · Cited by 79 · see citing works

Liraglutide, a human glucagon‐like peptide‐1 analogue, stimulates AKT‐dependent survival signalling and inhibits pancreatic β‐cell apoptosis

Kapodistria, K., Tsilibary, E.-P. C., Kotsopoulou, E. S., Moustardas, P., & Kitsiou, P. V. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13259 · Cited by 68 · see citing works

Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone

Lamounier, R. N., Coimbra, C. N., White, P., Costal, F., de Oliveira, L. S., Giannella‐Neto, D., Kaestner, K. H., & Corrêa‐Giannella, M. L. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-1 · Cited by 67 · see citing works

Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice

Okauchi, S., Shimoda, M., Obata, A., Kimura, T., Hirukawa, H., Kohara, K., Mune, T., Kaku, K., & Kaneto, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.109 · Cited by 64 · see citing works

Sex differences in islet stress responses support female β cell resilience

Brownrigg, G. P., Xia, Y. H., Chu, C. M. J., Wang, S., Chao, C. F., Zhang, J. A., Skovsø, S., Panzhinskiy, E., Hu, X., Johnson, J. D., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101678 · Cited by 62 · see citing works

Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes

Hamamoto, S., Kanda, Y., Shimoda, M., Tatsumi, F., Kohara, K., Tawaramoto, K., Hashiramoto, M., & Kaku, K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12005 · Cited by 60 · see citing works

Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes

Kimura, T., Kaneto, H., Shimoda, M., Hirukawa, H., Okauchi, S., Kohara, K., Hamamoto, S., Tawaramoto, K., Hashiramoto, M., & Kaku, K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.018 · Cited by 60 · see citing works

Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β‐cells in db/db mice: The earlier and longer, the better

Kimura, T., Obata, A., Shimoda, M., Okauchi, S., Kanda‐Kimura, Y., Nogami, Y., Moriuchi, S., Hirukawa, H., Kohara, K., Nakanishi, S., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13400 · Cited by 51 · see citing works

Glucagon-like peptide-1 production in the GLUTag cell line is impaired by free fatty acids via endoplasmic reticulum stress

Hayashi, H., Yamada, R., Das, S., Sato, T., Takahashi, A., Hiratsuka, M., & Hirasawa, N. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.012 · Cited by 44 · see citing works

Antidiabetic and hypolipidemic effects of Dorema aucheri hydroalcoholic leave extract in streptozotocin-nicotinamide induced type 2 diabetes in male rats.

Ahangarpour, A., Zamaneh, H. T., Jabari, A., Nia, H. M., & Heidari, H. (2014) · Europe PMC (PubMed Central) · Cited by 37 · see citing works

Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure

Kimura, T., Obata, A., Shimoda, M., Hirukawa, H., Kanda‐Kimura, Y., Nogami, Y., Kohara, K., Nakanishi, S., Mune, T., Kaku, K., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.10.007 · Cited by 37 · see citing works

Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets

Chen, L., So, W. Y., Li, S. Y. T., Cheng, Q., Boucher, B. J., & Leung, P. S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.029 · Cited by 36 · see citing works

Choice of therapy in patients with type 2 diabetes inadequately controlled with metformin and a sulphonylurea: a systematic review and mixed-treatment comparison meta-analysis.

McIntosh, B., Cameron, C. G., Singh, S. R., Yu, C., Dolovich, L., & Houlden, R. L. (2012) · Europe PMC (PubMed Central) · Cited by 34 · see citing works

The direct effect of lobeglitazone, a new thiazolidinedione, on pancreatic beta cells: A comparison with other thiazolidinediones

Kwon, M. J., Lee, Y., Jung, H. S., Shin, H. M., Kim, T. N., Lee, S. H., Rhee, B. D., Kim, M.-K., & Park, J. H. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.04.006 · Cited by 34 · see citing works

Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice

Kanda, Y., Hashiramoto, M., Shimoda, M., Hamamoto, S., Tawaramoto, K., Kimura, T., Hirukawa, H., Nakashima, K., & Kaku, K. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.10.007 · Cited by 32 · see citing works

Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β‐cell glucose toxicity: “the earlier, the better”

Kaneto, H., Matsuoka, T., Kimura, T., Obata, A., Shimoda, M., Kamei, S., Mune, T., & Kaku, K. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12331 · Cited by 27 · see citing works

Mechanism for antioxidative effects of thiazolidinediones in pancreatic β-cells

Chung, S. S., Kim, M., Lee, J. S., Ahn, B. Y., Jung, H. S., Lee, H. M., & Park, K. S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2011 · Cited by 26 · see citing works

Prophylactic and Ameliorative Effects of PPAR-γ Agonist Pioglitazone in Improving Oxidative Stress, Germ Cell Apoptosis and Inflammation in Gentamycin-Induced Testicular Damage in Adult Male Albino Rats

El-Sayed, K., Ali, D. A., Maher, S. A., Ghareeb, D., Selim, S., Albogami, S. M., Fayad, E., & Kolieb, E. (2022) · Antioxidants · doi:10.3390/antiox11020191 · Cited by 25 · see citing works

Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabetic db/db mice through the augmentation of IRS-2 expression

Hirukawa, H., Kaneto, H., Shimoda, M., Kimura, T., Okauchi, S., Obata, A., Kohara, K., Hamamoto, S., Tawaramoto, K., Hashiramoto, M., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.010 · Cited by 23 · see citing works

A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin

Lim, S. K., Lee, S., Min, K., Lee, C. B., Kim, S. Y., Yoo, H. J., Kim, N. H., Kim, J. H., Oh, S., Won, J. C., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15526 · Cited by 22 · see citing works

Vitamin D Combined with Pioglitazone Mitigates Type-2 Diabetes-induced Hepatic Injury Through Targeting Inflammation, Apoptosis, and Oxidative Stress

Hamouda, H. A., Mansour, S. M., & El-Yamany, M. F. (2021) · Inflammation · doi:10.1007/s10753-021-01535-7 · Cited by 25 · see citing works

Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK

Deng, R., Nie, A., Jian, F., Liu, Y., Tang, H., Zhang, J., Zhang, Y., Shao, L., Li, F., Zhou, L., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.021 · Cited by 20 · see citing works

Overexpression of PPARγ Specifically in Pancreatic β-Cells Exacerbates Obesity-Induced Glucose Intolerance, Reduces β-Cell Mass, and Alters Islet Lipid Metabolism in Male Mice

Hogh, K. N., Craig, M. N., Uy, C. E., Nygrén, H., Asadi, A., Speck, M., Fraser, J. D., Rudecki, A. P., Baker, R. K., Orešič, M., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1076 · Cited by 20 · see citing works

Circadian-clock system in mouse liver affected by insulin resistance

Yang, S.-C., Tseng, H.-L., & Shieh, K. (2013) · Chronobiology International · doi:10.3109/07420528.2013.766204 · Cited by 20 · see citing works

Protective effects of fish oil and pioglitazone on pancreatic tissue in obese KK mice with type 2 diabetes

Iizuka, Y., Kim, H., Izawa, T., Sakurai, K., Hirako, S., Wada, M., & Matsumoto, A. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.10.007 · Cited by 19 · see citing works

Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice

Kim, G., Lee, Y.-H., Yun, M. R., Lee, J.-Y., Shin, E., Lee, B.-W., Kang, E. S., & Cha, B.-S. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.222 · Cited by 19 · see citing works

Effects of chronic exposure of clonal β‐cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP ‐1

Pathak, V., Vasu, S., Flatt, P. R., & Irwin, N. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12227 · Cited by 17 · see citing works

Cotton rat (Sigmodon hispidus) develops metabolic disorders associated with visceral adipose inflammation and fatty pancreas without obesity

Nakamura, T., Ichii, O., Irie, T., Kouguchi, H., Sotozaki, K., Chihara, M., Sunden, Y., Nagasaki, K., Tatsumi, O., Elewa, Y. H. A., et al. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2908-9 · Cited by 17 · see citing works

Rosiglitazone Promotes PPARγ-Dependent and -Independent Alterations in Gene Expression in Mouse Islets

Welters, H. J., Ouaamari, A. E., Kawamori, D., Meyer, J., Hu, J., Smith, D. M., & Kulkarni, R. (2012) · Endocrinology · doi:10.1210/en.2012-1243 · Cited by 16 · see citing works

Pioglitazone attenuates the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T15

Puddu, A., Sanguineti, R., Durante, A., & Viviani, G. L. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.05.089 · Cited by 15 · see citing works

An Ethanolic Extract of Lindera obtusiloba Stems, YJP-14, Improves Endothelial Dysfunction, Metabolic Parameters and Physical Performance in Diabetic db/db Mice

Lee, J.-O., Auger, C., Park, D. H., Kang, M., Oak, M., Kim, K. R., & Schini‐Kerth, V. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065227 · Cited by 14 · see citing works

AhR-Induced Anti-Inflammatory Effects on a Caco-2/THP-1 Co-Culture Model of Intestinal Inflammation Are Mediated by PPARγ

da Rocha, G. H. O., Müller, C., Przybylski-Wartner, S., Schaller, H., Riemschneider, S., & Lehmann, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313072 · Cited by 13 · see citing works

Mallotus roxburghianus modulates antioxidant responses in pancreas of diabetic rats

Roy, V. K., Chenkual, L., & Gurusubramanian, G. (2016) · Acta Histochemica · doi:10.1016/j.acthis.2015.12.007 · Cited by 10 · see citing works

Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes

Hirukawa, H., Hashiramoto, M., Tanizawa, Y., Kaku, K., & Pioglitazone and Sulfonylurea Remission from Type 2 Diabetes Mellitus and Anti‐Atherosclerosis in Japan (PREVENT‐J) study group (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12813 · Cited by 10 · see citing works

Pioglitazone therapy in mouse offspring exposed to maternal obesity

Kalanderian, A., Abate, N. I., Patrikeev, I., Wei, J., Vincent, K. L., Motamedi, M., Saade, G. R., & Bytautiene, E. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.013 · Cited by 10 · see citing works

Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice

Novelli, M., Canistro, D., Martano, M., Funel, N., Sapone, A., Melega, S., Masini, M., Tata, V. D., Pippa, A., Vecoli, C., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.071 · Cited by 9 · see citing works

Animal Models of Type 2 Diabetes, Obesity and Nonalcoholic Steatohepatitis – Clinical Translatability and Applicability in Preclinical Drug Development

Hansen, H. H., Hansen, G., Secher, T., Feigh, M., Veidal, S. S., Fosgerau, K., Jelsing, J., & Vrang, N. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_14 · Cited by 9 · see citing works

Rosiglitazone protects INS-1E cells from human islet amyloid polypeptide toxicity

Marmentini, C., Guimarães, D. S. P. S. F., de Lima, T. I., Teófilo, F. B. S., Silva, N. S., Soares, G. M., Boschero, A. C., & Kurauti, M. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175122 · Cited by 8 · see citing works

In vivo Evaluation of Two Thiazolidin-4-one Derivatives in High Sucrose Diet Fed Pre-diabetic Mice and Their Modulatory Effect on AMPK, Akt and p38 MAP Kinase in L6 Cells

Mudgal, J., Shetty, P., Reddy, N. D., Akhila, H. S., Gourishetti, K., Mathew, G., Nayak, P. G., Kumar, N., Kishore, A., Kutty, N. G., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00381 · Cited by 7 · see citing works

Effect of pioglitazone on the expression of ubiquitin proteasome system and autophagic proteins in rat pancreas with metabolic syndrome

Çaylı, S., Alimoğulları, E., Pişkin, İ., Bilginoğlu, A., & Nakkaş, H. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-021-10013-1 · Cited by 7 · see citing works

Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells

Park, S. Y., & Sohn, U. D. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0594-6 · Cited by 7 · see citing works

Combined therapy with pioglitazone and FGF21 mRNA synergistically ameliorates metabolic disorders in NAFLD rats

Huang, X., Xia, Z., Huang, Y., Sun, Y., Zhang, L., Xiong, W., & Zhang, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15146 · Cited by 5 · see citing works

Effect of metformin and pioglitazone on β-catenin and biochemical markers in sitagliptin-induced pancreatitis in diabetic rats

Murad, H. A. S., Saleh, H., Abdulaziz, G. S., Abdulsattar, M. A., & Ali, S. S. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-014-0278-8 · Cited by 4 · see citing works

Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study

Zamani, B., Tabatabizadeh, S. M., Gilasi, H., & Yazdani, S. (2023) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2022-0070 · Cited by 3 · see citing works

Therapeutic impacts of oral anti-diabetic drugs on Inflammatory Bowel Disease (IBD), a comprehensive review of clinical and preclinical studies

Niknejad, A., Hosseini, Y., Manesh, M. A. N., Navabakhsh, M., Peyrovinasab, A., Mavaddat, H., Miri, M. S., Hosseini, M., Büsselberg, D., & Abdolghaffari, A. H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04591-0 · Cited by 2 · see citing works

Dual PPAR-α/γ enhances beta cell identity, preserving islet structure in HF-fed mice

Fernandes‐da‐Silva, A., Santana-Oliveira, D. A., Miranda, R. A., Souza-Tavares, H., Silva-Veiga, F. M., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0180 · Cited by 2 · see citing works

ROLE OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) IN OBESITY-ASSOCIATED HYPERTENSION

Gupte, M. (2011) · UKnowledge (University of Kentucky) · Cited by 2 · see citing works

Anti-diabetic drug pioglitazone reduces Islet amyloid aggregation overload in the Drosophila neuronal cells

Sharma, K., Rai, P., Maurya, S. K., & Tapadia, M. G. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03632-4 · Cited by 1 · see citing works

Glitazones Exert Multiple Effects on β-Cell Stimulus-Secretion Coupling

Düfer, M., Noack, K., Edalat, A., Krippeit‐Drews, P., & Drews, G. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081638 · Cited by 1 · see citing works

PPAR agonists in the treatment of diabetes

Mudaliar, S. R. D., & Henry, R. R. (2015) · doi:10.1002/9781118387658.ch44

Mechanisms of transcriptional regulation in the maintenance of β cell function

Maganti, A. V. (2015) · IUScholarWorks (Indiana University) · doi:10.7912/c2b88b

[New classification of vesicoureteral reflux].

Casado, J. S., Chaparro, L. P., Borda, A. P., Diego García, A., González, M. R., Moyano, A. S., & Estévez, L. R. (1992) · PubMed

Treatment with Oral Drugs

Bianchi, C., Daniele, G., Dardano, A., & Prato, S. D. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_19-1

Treatment with Oral Drugs

Bianchi, C., Daniele, G., Dardano, A., & Prato, S. D. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_19

Peroxisomes during postnatal development of mouse endocrine and exocrine pancreas display cell-type- and stage-specific protein composition

Colasante, C., Bonilla-Martinez, R., Berg, T., Windhorst, A., & Baumgart‐Vogt, E. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03766-6

Pioglitazone/Exenatide/SGLT-2 inhibitor combination therapy versus insulin therapy in patients with poorly controlled type 2 diabetes

Düğer, H., & Uçan, B. (2024) · Anatolian Current Medical Journal · doi:10.38053/acmj.1415215

Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice: possible protection of β cells from oxidative stress

Ishida, H., Takizawa, M., Ozawa, S., Nakamichi, Y., Yamaguchi, S., Katsuta, H., Tanaka, T., Maruyama, M., Katahira, H., Yoshimoto, K., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.021 · Cited by 138 · see citing works

Structural and functional analysis of pancreatic islets preserved by pioglitazone in <i>db/db</i> mice

Kawasaki, F., Matsuda, M., Kanda, Y., Inoue, H., & Kaku, K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00128.2004 · Cited by 99 · see citing works

The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes

Shimoda, M., Kanda, Y., Hamamoto, S., Tawaramoto, K., Hashiramoto, M., Matsuki, M., & Kaku, K. (2011) · Diabetologia · doi:10.1007/s00125-011-2069-9 · Cited by 161 · see citing works

Pioglitazone attenuates fatty acid–induced oxidative stress and apoptosis in pancreatic β‐cells

Saitoh, Y., Chun‐ping, C., Noma, K., Ueno, H., Mizuta, M., & Nakazato, M. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00749.x · Cited by 41 · see citing works

Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes

Kimura, T., Kaneto, H., Shimoda, M., Hirukawa, H., Okauchi, S., Kohara, K., Hamamoto, S., Tawaramoto, K., Hashiramoto, M., & Kaku, K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.018 · Cited by 60 · see citing works